A new injection for high cholesterol
Part of Hormones & metabolism clinical trials.
This study tests an experimental injection called DNV001 for people with high cholesterol or mixed high cholesterol (high LDL and triglycerides). It aims to see if it can lower cholesterol further when added to your current statin medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a diagnosis of high cholesterol (primary hypercholesterolemia) or mixed high cholesterol (mixed hyperlipidemia) and are already taking a stable dose of a statin medication.
- Your LDL cholesterol levels must be at least 70 mg/dL if you have had a heart attack or stroke, or at least 100 mg/dL if you have not.
- Your triglyceride levels must be 400 mg/dL or lower.
- You are willing to stay on the same statin dose during the study and follow lifestyle advice (diet and exercise).
- You agree to use reliable birth control if you are able to become pregnant or if you are a male not vasectomized.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injectable medication called HST101 for lowering cholesterol in people who are already taking cholesterol pills but still have high levels. It may help if you have heart disease or are at high risk.
This study tests how a new drug moves through the body and affects cholesterol levels. It is for people with moderately high cholesterol who are otherwise healthy.
This Phase 3 study tests whether JS002 alone can lower LDL “bad” cholesterol in people whose levels are still too high for their heart-risk level. It will also check how safe the treatment is, especially for heart and metabolic side effects.
This trial tests a new medication (QLC7401) for people with high cholesterol that is not well controlled by their current treatment. It aims to see if the drug can help lower LDL-C (bad cholesterol) levels and reduce the risk of heart problems.
This trial tests a new injection called ART002g1 for people with a genetic condition that causes very high cholesterol. It aims to see if the drug is safe and can help lower cholesterol levels.
This trial tests if a new drug, QLC7401, can lower cholesterol in people with high cholesterol who are not on other cholesterol medicines. It may be an option if you have low or medium risk of heart disease and no history of heart problems.
Hear when a new Primary Hypercholesterolemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.